Life Sciences

In today's rapidly evolving legal and public policy environment, companies involved in the life sciences sector face a broad spectrum of complex issues. At Perley-Robertson, Hill & McDougall LLP, we have a depth of specific experience advising start-up, early stage and mature companies in the biotech, bio-pharmaceutical, photonics, convergence, pharmacogenomics, ag-biotech, animal health and environmental sectors.

We work with research institutions including those associated with hospitals, government agencies and universities, corporate research operations, and technology transfer offices, as well as the venture capital and investment banking communities.

By drawing together a multi-disciplinary life sciences team from a number of practice areas including finance, corporate and commercial law, mergers and acquisitions, tax law and litigation, we can provide guidance and advice in a wide range of areas, including:

• Access to research grants from governments and private funding agencies
• Intellectual property
• Competition law and International trade
• The Food and Drug Act
• Online sales
• Marketing and price controls
• Public policy
• Privacy

We provide specific advice on key issues for the life sciences sector, including:

• Those encountered by hospitals and academic health sciences centres.
• Advising on intellectual property law, including developing and implementing intellectual property protection strategies, preparing and filing patents, and managing an intellectual property portfolio.
• Advising on mergers and acquisitions.
• Advising on Federal and provincial regulatory compliance.
• Negotiating and structuring licensing arrangements and strategic alliances.
• Performing due diligence activities.
• Providing strategic advice on emerging legal issues and bioethics
• Representing companies and investors in financing transactions.
• Resolving disputes.